Evidence map›Paper›PMID 40050438›Full record

ArticleNature chemical biology2025

Molecular basis of β-arrestin coupling to the metabotropic glutamate receptor mGlu3.

Tianlei Wen, Mei Du, Yue Lu, Nan Jia, Xuhang Lu, Ning Liu, Shenghai Chang, Xing Zhang, Yuequan Shen, Xue Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Stabilized DNature communications · 2025
    Article
  13. Unveiling the molecular mechanism of GProtein science : a publication of the Protein Society · 2025
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tianlei Wen *State Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin, China.ORCID http://orcid.org/0000-0001-5321-0093
Mei Du *College of Pharmacy, Nankai University, Tianjin, China.
Yue LuState Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin, China.ORCID http://orcid.org/0009-0003-4911-5765
Nan JiaState Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin, China.ORCID http://orcid.org/0009-0006-7434-0608
Xuhang LuState Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin, China.ORCID http://orcid.org/0000-0003-3677-0333
Ning LiuState Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin, China.
Shenghai ChangDepartment of Biophysics of Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Xing ZhangDepartment of Biophysics of Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0002-6776-326X
Yuequan ShenState Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin, China. yshen@nankai.edu.cn.ORCID http://orcid.org/0000-0002-3775-0900
Xue YangState Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin, China. yangxue@nankai.edu.cn.ORCID http://orcid.org/0000-0002-4960-0950

Funding

China Postdoctoral Science Foundation 2024M761516National Natural Science Foundation of China (National Science Foundation of China) 32071231National Natural Science Foundation of China (National Science Foundation of China) 32271288National Natural Science Foundation of China (National Science Foundation of China) 32471269
6 · The paper itself

Abstract

β-Arrestins (βarrs) mediate the desensitization and internalization of activated G-protein-coupled receptors (GPCRs). The molecular mechanism by which dimeric family C GPCR members recruit arrestins remains elusive. Here we report two structures of metabotropic glutamate receptor subtype 3 (mGlu3) coupled to βarr1, with stoichiometries of 2:1 and 2:2. The L-glutamate-bound mGlu3 dimer adopts an inactive state, with both Venus flytrap domains closed, engaging βarr1 either asymmetrically or symmetrically. The transmembrane domain of the mGlu3 protomer interacts with βarr1 through a binding pocket formed by three intracellular loops and an ordered C-terminal region. Three phosphorylation sites (pS857, pS859 and pT860) on the C-terminal tail of mGlu3 engage the N domain of βarr1. βarr1 stabilizes mGlu3 in an inactive conformation, characterized by a TM3/TM4-TM3/TM4 dimeric interface, previously observed in the negative allosteric modulator-bound structure of mGlu3. Our findings provide important insights into βarr-mediated inactivation of family C GPCRs.

Indexed as

beta-Arrestin 1Receptors, Metabotropic GlutamateCryoelectron MicroscopyDimerizationHEK293 CellsHumansProtein Conformationbeta-Arrestin 1metabotropic glutamate receptor 3Receptors, Metabotropic Glutamate

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.